Chamaecostus cuspidatus

Ethnobotanical Studies

Studies

From Flora to Pharmaceuticals: 100 new additions to angiosperms of Gafargaon subdistrict in Bangladesh and unraveling antidiabetic drug candidates targeting DPP4 through in silico approach.

Summary

Researchers identified 100 new angiosperm species in Gafargaon, Bangladesh, including Chamaecostus cuspidatus with potential for antidiabetic drug development. Virtual screening revealed two lead compounds with promising properties. Study enriches biodiversity knowledge and may lead to new diabetes treatments.

Ahmed SS and Rahman MO (2024).
PLoS One.
PubMed:
38551991

Biosynthesis of ZnONP Using Chamaecostus cuspidatus and Their Evolution of Anticancer Property in MCF-7 and A549 Cell Lines.

Balaji MP et al (2022).
Nanomaterials (Basel).
PubMed:
36234511

Identification and quantification of phytochemicals of Chamaecostus cuspidatus (Nees & Mart.) C.D.Specht & D.W.Stev and Cheilocostus speciosus (J. Koenig) C.D.Specht by LC-MS techniques and their in-vitro anti-adipogenic screening.

Shukla V et al (2022).
Nat Prod Res.
PubMed:
35285353

In Vivo Type 2 Diabetes and Wound-Healing Effects of Antioxidant Gold Nanoparticles Synthesized Using the Insulin Plant Chamaecostus cuspidatus in Albino Rats.

Ponnanikajamideen M et al (2019).
Can J Diabetes.
PubMed:
30413371